World Stem Cell Summit
the original, translation-focused global meeting of stakeholders
The Summit will be co-located with the field's premier industry partnering event, Phacilitate Leaders Forum, Cell & Gene Therapy World and Immunotherapy WorldLearn More
The World Stem Cell Summit is a project of the nonprofit Regenerative Medicine Foundation.
We rely on the support of donors like you to further our mission: to accelerate regenerative medicine to improve health and deliver cures.
The Global StemCell Translational MeetingSee Last Year's Program
Read more:Diabetes Research Institute Foundation
Read more:Mayo Clinic
Read more:Nova Southeastern University
Read more:The Cure Alliance
Read more:University of Miami Miller School of Medicine
Read more:Wake Forest Institute for Regenerative Medicine
Cellular Dynamics International (CDI), a FUJIFILM company, is a leading developer and manufacturer of human cells used in drug discovery, toxicity testing, stem cell banking, and cell therapy development. The Company partners with innovators from around the world to combine biologically relevant human cells with the newest technologies to drive advancements in medicine and healthier living. CDI’s technology offers the potential to create induced pluripotent stem cells (iPSCs) from anyone, starting with a standard blood draw, and followed by the powerful capability to develop into virtually any cell type in the human body. Our proprietary manufacturing system produces billions of cells daily, resulting in inventoried iCell® products and donor-specific MyCell® Products in the quantity, quality, purity, and reproducibility required for drug and cell therapy development. Founded in 2004 by Dr. James Thomson, a pioneer in human pluripotent stem cell research, Cellular Dynamics is based in Madison, Wisconsin, with a second facility in Novato, California. For more information, please visit www.cellulardynamics.com, and follow us on Twitter @CellDynamics. FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2015, the company had global revenues of $20.8 billion, at an exchange rate of 120 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.Cellular Dynamics